Abstract:Glioma accounts for the majority of primary malignant brain tumors in adults and is highly aggressive. Although various therapeutic approaches have been applied, outcomes of glioma treatment remain poor. Acquiring a better understanding of the pathogenic mecha nisms is essential to the design of effective therapeutic strategies. Previous studies have found that miR-520d-5p was negatively correlated with glioma grade, but its role and mechanism in glioma progression remain largely unknown. In the present study, we reported that miR-520d-5p directly targeted the Pituitary Tumor Transforming Gene 1 (PTTG1) and functioned as a tumor-suppressor in glioma. The expression of miR-520d-5p in glioma cells and specimens were detected by Quantitative reverse transcription-PCR and Fluorescence in situ hybridization (FISH). The effects of miR-520d-5p on glioma progression was examined by cell-counting kit 8, colony formation, 5-ethynyl-2-deoxyuridine (EDU) and flow cytometry assays. Using bioinformatics and luciferase reporter assays, we identified PTTG1 as a novel and direct target of miR-520d-3p. A xenograft model was used to study the effect of miR-520d-5p on tumor growth and angiogenesis. We found that miR-520d-5p expression was significantly decreased in glioma cell lines and tissues. Overexpression of miR-520d-5p showed a significant inhibitory effect on cell proliferation and accompanied cell cycle G0/G1 arrest in U87-MG and LN229 glioma cells. PTTG1 was a novel and direct target of miR-520d-5p, and the protein expression of PTTG1 was markedly reduced after overexpression of miR-520d-5p in U87-MG and LN229 cells. Overexpression of PTTG1 reversed the inhibitory effect of miR-520d-5p on glioma cell proliferation. In vivo studies confirmed that miR-520d-5p overexpression retarded the growth of U87 xenograft tumors, which was accompanied by reduced expression of PTTG1. In conclusion, these results provide compelling evidence that miR-520d-5p functions as an anti-onco-miRNA, which is important in inhibiting cell proliferation in GBM, and its anti-oncogenic effects are medi ated chiefly through direct suppression of PTTG1 expression. Therefore, we suggest that miR-520d-5p is a potential candidate for the prevention of glioblastoma.

Lentivirus-mediated Knockdown of Tumor Protein D52-like 2 Inhibits Glioma Cell Proliferation.

Tpd52l2 Silencing Inhibits Lung Cancer Cell Proliferation By Cell Cycle G2/M Phase Arrest

Lentivirus-mediated TPD52L2 Depletion Inhibits the Proliferation of Liver Cancer Cells in Vitro.

Long Noncoding RNA LINC00052 Suppressed the Proliferation, Migration and Invasion of Glioma Cells by Upregulating KLF6.

Retracted: Lentivirus-Mediated Tpd52l2 Depletion Inhibits The Proliferation Of Liver Cancer Cells In Vitro (Retracted Article. See Vol. 9, Pg. 12416, 2016)

Knockdown of Akt2 Expression by Rna Interference Inhibits Proliferation, Enhances Apoptosis, and Increases Chemosensitivity to the Anticancer Drug Vm-26 in U87 Glioma Cells

Lentivirus-Mediated Knockdown of TCTN1 Inhibits Glioma Cell Proliferation.

Knockdown of Angiopoietin-Like Protein 2 Inhibits Proliferation and Invasion in Glioma Cells Via Suppressing the ERK/MAPK Signaling Pathway.

Inhibition of Human Glioma Cell Proliferation Caused by Knockdown of Utrophin Using A Lentivirus-Mediated System

Lentivirus-mediated Knockdown of CTDP1 Inhibits Lung Cancer Cell Growth in Vitro.

RNA interference-mediated knockdown of translationally controlled tumor protein induces apoptosis, and inhibits growth and invasion in glioma cells

DTX2 Promotes Glioma Development Via Regulation of HLTF

Downregulation of Ubiquitin-Associated Protein 2-Like with a Short Hairpin RNA Inhibits Human Glioma Cell Growth in Vitro.

P11.52 Reduced Expression of Proteolipid Protein 2 Increases ER-stress-induced Apoptosis and Autophagy in Glioblastoma

MicroRNA-520 D-5 P Inhibits Human Glioma Cell Proliferation and Induces Cell Cycle Arrest by Directly Targeting PTTG 1

GGNBP2 Suppresses the Proliferation, Invasion, and Migration of Human Glioma Cells.

Knockdown of SLC34A2 inhibits cell proliferation, metastasis, and elevates chemosensitivity in glioma.

TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells.

Tristetraprolin Exerts Tumor Suppressive Functions on the Tumorigenesis of Glioma by Targeting IL-13.

LATS2 inhibits cell proliferation and metastasis through the Hippo signaling pathway in glioma

PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor